Vasopressin and terlipressin in adult vasodilatory shock

Polito, Angelo; Parisini, Emilio; Ricci, Zaccaria; Picardo, Sergio; Annane, Djillali

doi:10.1186/cc11887

Cited by 2 publications

(4 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The heart rate was significantly stabilized in the vasopressin group. Vasopressin infusion reduced the heart rate in patients with sepsis and those undergoing cardiac surgery, 4,9 which was consistent with the present findings. Although there were no significant intergroup differences, all other hemodynamic parameters were significantly higher in the vasopressin group.…”

Section: Discussionsupporting

confidence: 92%

“…A recent review article reported a superior outcome when vasopressin was administered to patients with vasodilatory shock (vasoplegia) compared with norepinephrine. 4 Low serum vasopressin concentration is associated with postcardiac surgery vasoplegia, and vasopressin administration effectively remedies this. 5,6 A few randomized controlled trials [7][8][9] have been conducted with patients undergoing coronary artery bypass grafting (CABG) with a high risk of vasoplegia and moderately reduced left ventricular function, 7 as well as patients with moderately reduced left ventricular function 8 and off-pump CABG in stable condition.…”

mentioning

confidence: 98%

See 1 more Smart Citation

Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial

Okamoto

Nohmi

Higa

et al. 2015

Journal of Cardiothoracic and Vascular Anesthesia

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 92%

mentioning

confidence: 98%

Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial

Okamoto

Nohmi

Higa

et al. 2015

Journal of Cardiothoracic and Vascular Anesthesia

View full text Add to dashboard Cite

“…The results indicated norepinephrine to be a more prudent choice [19]. Initial studies indicated that dopamine increases contractility of myocardial tissues allowing the effect of pharmacological titration, and hence, it has been considered and recommended as the first choice for treating shock [27,28].…”

Section: Discussionmentioning

confidence: 99%

“…All the statistical analyses were done with regard to the principle of intention-to-treat [19]. An unadjusted chi-square test was employed to analyze the differences in the primary outcome.…”

Section: Analyzing Statisticsmentioning

confidence: 99%

Comparing the Use of Dopamine and Norepinephrine in Shock Treatment

Jalalyazdi¹,

Parvizian²,

Abyaneh³

2016

Cardiovasc Pharm Open Access

View full text Add to dashboard Cite

IntroductionCardiovascular shock refers to a critical condition that occurs when a patient's heart suddenly fails to pump blood as required by the body. This rare but fatal condition is mostly caused by heart attack and is linked to high death rate [1,2]. The fluid administration that forms the firstline of therapeutic strategy does not offer enough stability for the condition of the patient, and the adrenergic agents are regularly needed to correct hypertension [3]. Among the most frequently used agents are dopamine and norepinephrine. Both dopamine and norepinephrine affect the alpha-adrenergic and beta-adrenergic receptors, though to varying degrees. The effects of alpha-adrenergic receptors lead to increased vascular tone. However, it could decrease the cardiac output as well as the regional flow of blood, particularly in cutaneous, renal, and splanchnic beds [4].On the other hand, beta-adrenergic effects assist in the maintenance of blood flow through inotropic and chronotropic effects as well as increasing splanchnic perfusion. This stimulation from the betaadrenergic effects can bring out the unwanted consequences, including an increase in the cellular metabolism and immunosuppressive effects [5]. Besides, dopamine arouses dopaminergic receptors, which leads to a uniformly bigger rise in renal and splanchnic perfusion, which can expedite lung edema tenacity. Conversely, the stimulation caused by dopamine could lead to negative immunological effects by modifying hypothalamic-pituitary function, leading to a patent drop of prolactin as well as the level of hormones [6].Hypothetically, norepinephrine and dopamine have varying effects in the splanchnic, kidney and pituitary axis, though the medical consequences of the implied differences are not certain [7]. Experts have recommended that any of the two compounds may be chosen first and applied as a vasopressor in patients suffering from shock. Studies have Comparing the Use of Dopamine and Norepinephrine in Shock Treatment AbstractBackground: The vasopressor agents, such as norepinephrine and dopamine have been endorsed as the standard choice for shock treatment. However, there is controversy regarding the use of vasopressor agents for shock treatment. Considering the use of norepinephrine over dopamine, the present study aimed at assessing the reasons for the reduced death rate among the patients who were in shock.

show abstract

Vasopressin and terlipressin in adult vasodilatory shock

Cited by 2 publications

References 3 publications

Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial

Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial

Comparing the Use of Dopamine and Norepinephrine in Shock Treatment

Contact Info

Product

Resources

About